Drug Resistance, Multiple
"Drug Resistance, Multiple" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Simultaneous resistance to several structurally and functionally distinct drugs.
| Descriptor ID |
D018432
|
| MeSH Number(s) |
G07.690.773.984.300
|
| Concept/Terms |
Drug Resistance, Multiple- Drug Resistance, Multiple
- Multiple Drug Resistance
- Resistance, Multiple Drug
- Multidrug Resistance
- Multi-Drug Resistance
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple".
This graph shows the total number of publications written about "Drug Resistance, Multiple" by people in this website by year, and whether "Drug Resistance, Multiple" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 5 | 2 | 7 |
| 1997 | 3 | 2 | 5 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 2 | 3 |
| 2000 | 5 | 0 | 5 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 2 | 2 |
| 2007 | 1 | 2 | 3 |
| 2008 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 3 | 4 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 0 | 2 |
| 2016 | 2 | 1 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Resistance, Multiple" by people in Profiles.
-
Evolutionary Responses to Acquiring a Multidrug Resistance Plasmid Are Dominated by Metabolic Functions across Diverse Escherichia coli Lineages. mSystems. 2023 02 23; 8(1):e0071322.
-
Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient. Pediatr Pulmonol. 2020 11; 55(11):2990-2994.
-
Multiple drug resistance in the canine hookworm Ancylostoma caninum: an emerging threat? Parasit Vectors. 2019 Dec 09; 12(1):576.
-
Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and Outcomes. Chemotherapy. 2017; 62(2):100-104.
-
NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function. Br J Pharmacol. 2016 Feb; 173(3):613-26.
-
Cancer cell-selective killing polymer/copper combination. Biomater Sci. 2016 Jan; 4(1):115-20.
-
A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells. BMC Cancer. 2014 Sep 19; 14:681.
-
Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925. Br J Cancer. 2014 Jun 10; 110(12):2896-904.
-
Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease. Bioorg Med Chem. 2013 Dec 01; 21(23):7430-4.
-
The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer. Eur J Pharm Sci. 2014 Jan 23; 51:96-109.